Quantitative microfluidic biochip and method of use

• US 20020127740A1
• Filed: 10/09/2001
• Published: 09/12/2002
• Est. Priority Date: 03/06/2001
• Status: Abandoned Application

• Current Assignee: Ho, Winston Z.
• Original Assignee: Ho, Winston Z.
• Inventors: Ho, Winston Z.
• Application Number:
  US09/973,209
• Publication Number:
  US 20020127740A1
• Time in Patent Office: Days
• US Class Current: 436/518
• CPC Class Codes: B01L 3/5027 by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip B01L3/5023 takes precedence; micromixers B01F33/30; microreactors for synthesis B01J19/0093; microcapillary devices in general B81B1/00
• CPC Class Codes: C12Q 1/6837 using probe arrays or probe chips C12Q1/6874 takes precedence
• CPC Class Codes: C12Q 2565/629 being a microfluidic device
• CPC Class Codes: G01N 33/5302 Apparatus specially adapted for immunological test procedures
• CPC Class Codes: G01N 33/54326 Magnetic particles

Abstract

Method is disclosed to provide constant and consistent amount of samples or reagent solutions for performing biological assay in a microfluidic biochip platform. A method and apparatus comprises a plurality of microfluidic channels with constant cross-section area in closed confinement, said microfluidic channels transporting fluids to at least one reaction zone immobilized with biological probes. The fluids in said microfluidic channels is transported to said reaction zone and reacted with the probes. The reaction volume, which is equal to the cross-section area multiply with the length of said channel overlaid on said reaction zone, is therefore a constant number. In addition, a method for immobilizing an array of biological probes in the microfluidic biochip arrangement, which is simple, flexible, and controllable for immobilizing, removing, and replenishing new probes is disclosed.

Claims

1. A method for performing biological assay in a microfluidic biochip platform providing constant and consistent reaction volume defining a reaction zone, the method comprising the steps of:

(a) providing a plurality of microfluidic channels with a constant cross-section area;

(b) immobilizing at least one biological probe on said reaction zone; and

(c) transporting fluid in said microfluidic channels to said reaction zone, a portion of said fluid reacting with said at least one probe, wherein said reaction volume is product of said cross-section area multiplied with length of said microfluidic channels having said at least one biological probe.

2. The method as defined in claim 1, wherein a portion of said microfluidic channels has serpent-like structure, said serpent-like structure overlaying with at least a portion of said reaction zone.

3. The method as defined in claim 1 or 2, wherein said microfluidic channels have dimension between 0.5 μ

m and 2 mm in cross-section.

4. The method as defined in claim 1 or 2, the microfluidic biochip platform further comprising at least one sample source and at least one reagent solution, wherein a portion of said microfluidic channels is connected to said at least one sample source and to said at least one reagent solution.

5. The method defined in claim 1 or 2, wherein said fluid in said microfluidic channels is moved by a pressurizing mechanism for providing a forward-moving fluid.

6. The method defined in claim 1 or 2, the method further comprising the steps of:

(a) immobilizing said at least one biological probe on magnetic beads;

(b) transporting said magnetic beads through said microfluidic channels;

(c) providing at least one external magnet from magnet sources beneath said reaction zone; and

(d) switching on said at least one external magnet to trap said magnetic beads.

7. The method defined in claim 2, wherein said biochip platform further comprises:

(a) said at least one biological probe immobilized on said reaction zone of a base plate;

(b) said microfluidic channels patterned on a bottom surface of a top plate; and

(c) said top plate coupled on top of said base plate.

8. The microfluidic biochip platform according to claim 1 or 2, wherein said probe is protein.

9. The microfluidic biochip platform according to claim 1 or 2, wherein said probe is nucleic acid.

10. The microfluidic biochip platform according to claim 1 or 2, wherein said probe is biological cell.

11. The microfluidic biochip platform according to claim 1 or 2 further comprising an optical detector located above said reaction zone.

13. The method defined in claim 12, wherein said external magnets have on and off switching mechanisms for immobilizing or removing said biological probe in said microfluidic channels;

and an electronic means for controlling said on and off switching mechanisms.

14. The method as defined in claim 12, wherein said microfluidic channels have dimension between 0.5 μ

m and 2 mm in cross-section.

15. The method as defined in claim 12, the biochip further comprising at least one sample source and at least one reagent solution, wherein a portion of said microfluidic channels is connected to said at least one sample source and to said at least one reagent solution.

16. The method defined in claim 12, wherein said fluid in said microfluidic channels is moved by a pressurizing mechanism for providing a forward-moving fluid.

17. The biochip according to claim 12, wherein said probe is protein.

18. The biochip according to claim 12, wherein said probe is nucleic acid.

19. The biochip according to claim 12, wherein said probe is biological cell.

20. The biochip according to claim 12 further comprising an optical detector located above said microfluidic channels.

12. A method for performing biological assay in a biochip with an array of microfluidic channels providing flexible and controllable immobilization for at least one biological probe, the method comprising the steps of:

(a) immobilizing said at least one biological probe on magnetic beads;

(b) selecting at least one of said magnetic beads and transporting said magnetic beads through one of said microfluidic channels;

(c) providing at least one external magnet beneath a portion of said microfluidic channels; and

(d) switching on said at least one external magnet for immobilization of at least one of said at least one biological probe.